Ambev S.A. (NYSE: ABEV)

$2.80-1.41%today

Brazilian ADR trading on the NYSE, priced in US dollars.

Display currency

Market Cap, EPS and the financial totals below — switch between US dollars and BRL.

Market Cap: $43.18B
P/E (TTM): 14.0x
P/B: 2.5x
EPS (TTM): $0.20
Dividend Yield: 6.04%
52-Week Range: $2.10 – $3.45
Volume: 37.05M
Previous Close: $2.84

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

-1.41%

1 Week

-4.76%

1 Month

-7.59%

YTD

+13.36%

1 Year

+27.85%

5 Years

-8.50%

About Ambev S.A.

US Ticker: ABEV
B3 Ticker: ABEV3
Exchange: NYSE
Currency: USD
Sector: Consumer Defensive
Industry: Beverages - Brewers
Headquarters: São Paulo, SP, Brazil
Employees: 39,000
CEO: Mr. Carlos Eduardo Klutzenschell Lisboa
Founded: 1853

Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, soft drinks, malt and food, and other beverages in Brazil, Central America and Caribbean, Latin America South, and Canada.

The company offers beer, ready-to-drink cocktails and spritzers, soft drinks, water, teas, and isotonic drinks under the Brahma, Skol, Antarctica, Original, Quilmes, Andes Origen, Patricia, Paceha, Huari, Pilsen, Presidente, Balboa, Guaraná Antarctica, and Beats brands.

It sells its products to distributors, supermarkets, and retailers within a broad distribution network.

The company was founded in 1853 and is headquartered in São Paulo, Brazil.

Ambev S.A. operates as a subsidiary of Interbrew International B.V.

www.ambev.com.br

Analyst Ratings

Consensus of 10 Wall Street analysts · sourced from Yahoo Finance

3.0Hold

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$2.60

Average

$3.34

High

$4.00

The average target is +19.27% above the current price of $2.80.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from Ambev S.A.'s income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Strong

Net Margin: 18.4%
ROE: 18.4%
Rev Growth (YoY): +0.03%
Net Debt / EBITDA: -0.46×
Current Ratio: 1.02×
Interest Coverage: 8.50×
Free Cash Flow: 24.02B
Payout Ratio: 79.7%

Income — Margins & Efficiency

Metric	Last 12MQ3'25 – Q2'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Revenue	$17,057,666,725	+5.9%	$16,113,819,802	+11.3%	$14,479,467,133	-11.9%	$16,439,920,003	+9.0%	$15,083,222,950	+15.3%	$13,079,296,973	+16.3%	$11,246,544,152	-13.2%	$12,950,409,031	-0.1%	$12,965,592,897	-10.4%	$14,466,280,088	+3.2%	$14,021,646,220	+18.7%	$11,807,870,195	-17.7%	$14,347,537,772	-3.5%	$14,868,435,553	-6.4%	$15,881,032,712	+9.2%	$14,543,587,819	-4.2%	$15,182,490,975	+14.1%	$13,306,942,054	+49.3%	$8,912,736,661	-19.6%	$11,078,764,217	+34.0%	$8,265,462,224
Gross profit	$8,853,469,766	+6.8%	$8,286,476,024	+11.7%	$7,419,608,605	-11.0%	$8,338,893,242	+12.2%	$7,434,186,126	+11.3%	$6,677,426,304	+10.7%	$6,032,338,896	-20.1%	$7,552,062,387	-5.6%	$7,996,980,022	-11.4%	$9,021,443,025	+1.4%	$8,893,583,003	+14.8%	$7,748,578,361	-18.6%	$9,519,309,747	-4.5%	$9,963,378,968	-6.8%	$10,694,098,088	+10.0%	$9,719,172,207	-3.8%	$10,098,856,799	+13.8%	$8,870,969,593	+52.8%	$5,807,013,769	-20.9%	$7,344,763,198	+34.2%	$5,473,955,889
Operating income	$4,701,007,208	+15.3%	$4,076,293,780	+15.5%	$3,528,982,340	-9.1%	$3,882,520,308	+16.0%	$3,347,046,134	+9.2%	$3,066,371,046	-0.3%	$3,076,997,765	-23.1%	$4,003,002,208	-9.6%	$4,426,952,661	-11.4%	$4,998,973,151	-5.0%	$5,259,477,908	+10.8%	$4,746,000,455	-20.4%	$5,963,075,996	-8.8%	$6,540,414,530	-2.3%	$6,694,831,549	+9.1%	$6,135,052,541	+1.7%	$6,030,625,752	+14.5%	$5,265,576,592	+56.4%	$3,367,685,026	-23.1%	$4,378,317,207	+115.2%	$2,034,772,407
EBITDA	$5,737,367,384	+8.4%	$5,290,986,450	+12.7%	$4,696,077,955	-6.2%	$5,003,814,276	+14.5%	$4,368,296,560	+15.9%	$3,768,859,287	-5.8%	$4,002,127,594	-17.3%	$4,841,807,590	-2.8%	$4,982,035,001	-13.1%	$5,732,717,224	-2.8%	$5,897,026,720	+11.9%	$5,267,596,735	-21.3%	$6,694,397,348	-6.1%	$7,128,936,549	-7.9%	$7,741,919,711	+7.0%	$7,232,897,276	+1.0%	$7,163,056,558	+14.3%	$6,265,920,826	+55.3%	$4,034,552,496	-21.3%	$5,128,218,186	+46.8%	$3,493,524,167
Net profit	$3,139,678,629	+10.9%	$2,831,050,729	+21.1%	$2,336,910,601	-21.8%	$2,989,959,177	+9.3%	$2,735,855,126	+20.3%	$2,274,783,670	+3.8%	$2,192,208,235	-25.3%	$2,933,478,032	+3.4%	$2,838,005,266	+29.3%	$2,195,342,937	-43.1%	$3,857,762,199	+22.9%	$3,139,939,849	-30.9%	$4,545,985,456	+12.2%	$4,050,904,929	+30.6%	$3,102,880,055	+12.5%	$2,759,167,918	-39.4%	$4,549,578,821	+32.5%	$3,434,366,036	+55.9%	$2,202,710,843	-22.2%	$2,831,098,286	+115.0%	$1,316,893,477
Gross margin	51.9%	+0.5 p.p.	51.4%	+0.2 p.p.	51.2%	+0.5 p.p.	50.7%	+1.4 p.p.	49.3%	-1.8 p.p.	51.1%	-2.6 p.p.	53.6%	-4.7 p.p.	58.3%	-3.4 p.p.	61.7%	-0.7 p.p.	62.4%	-1.1 p.p.	63.4%	-2.2 p.p.	65.6%	-0.7 p.p.	66.3%	-0.7 p.p.	67.0%	-0.3 p.p.	67.3%	+0.5 p.p.	66.8%	+0.3 p.p.	66.5%	-0.1 p.p.	66.7%	+1.5 p.p.	65.2%	-1.1 p.p.	66.3%	+0.1 p.p.	66.2%
Operating margin	27.6%	+2.3 p.p.	25.3%	+0.9 p.p.	24.4%	+0.8 p.p.	23.6%	+1.4 p.p.	22.2%	-1.3 p.p.	23.4%	-3.9 p.p.	27.4%	-3.6 p.p.	30.9%	-3.2 p.p.	34.1%	-0.4 p.p.	34.6%	-3.0 p.p.	37.5%	-2.7 p.p.	40.2%	-1.4 p.p.	41.6%	-2.4 p.p.	44.0%	+1.8 p.p.	42.2%	-0.0 p.p.	42.2%	+2.5 p.p.	39.7%	+0.2 p.p.	39.6%	+1.8 p.p.	37.8%	-1.7 p.p.	39.5%	+14.9 p.p.	24.6%
EBITDA margin	33.6%	+0.8 p.p.	32.8%	+0.4 p.p.	32.4%	+2.0 p.p.	30.4%	+1.5 p.p.	29.0%	+0.1 p.p.	28.8%	-6.8 p.p.	35.6%	-1.8 p.p.	37.4%	-1.0 p.p.	38.4%	-1.2 p.p.	39.6%	-2.4 p.p.	42.1%	-2.6 p.p.	44.6%	-2.0 p.p.	46.7%	-1.3 p.p.	47.9%	-0.8 p.p.	48.7%	-1.0 p.p.	49.7%	+2.6 p.p.	47.2%	+0.1 p.p.	47.1%	+1.8 p.p.	45.3%	-1.0 p.p.	46.3%	+4.0 p.p.	42.3%
Net margin	18.4%	+0.8 p.p.	17.6%	+1.4 p.p.	16.1%	-2.0 p.p.	18.2%	+0.0 p.p.	18.1%	+0.7 p.p.	17.4%	-2.1 p.p.	19.5%	-3.2 p.p.	22.7%	+0.8 p.p.	21.9%	+6.7 p.p.	15.2%	-12.3 p.p.	27.5%	+0.9 p.p.	26.6%	-5.1 p.p.	31.7%	+4.4 p.p.	27.2%	+7.7 p.p.	19.5%	+0.6 p.p.	19.0%	-11.0 p.p.	30.0%	+4.2 p.p.	25.8%	+1.1 p.p.	24.7%	-0.8 p.p.	25.6%	+9.6 p.p.	15.9%
Revenue growth (YoY)	0.0%	+1.4 p.p.	-1.4%	-13.5 p.p.	12.2%	+12.1 p.p.	0.0%	-9.4 p.p.	9.4%	-15.4 p.p.	24.8%	+12.5 p.p.	12.3%	+8.7 p.p.	3.5%	-1.3 p.p.	4.9%	-0.2 p.p.	5.0%	+7.4 p.p.	-2.4%	-25.1 p.p.	22.7%	+14.1 p.p.	8.6%	+0.5 p.p.	8.0%	-11.7 p.p.	19.7%	+12.2 p.p.	7.5%	-1.3 p.p.	8.8%	-3.2 p.p.	12.0%	+6.2 p.p.	5.8%	-5.4 p.p.	11.2%	—	—
Effective tax rate	17.9%	+0.3 p.p.	17.7%	-6.1 p.p.	23.8%	+23.3 p.p.	0.5%	+5.1 p.p.	-4.6%	-9.2 p.p.	4.6%	-8.4 p.p.	13.1%	+7.2 p.p.	5.8%	-7.7 p.p.	13.5%	-25.8 p.p.	39.3%	+37.0 p.p.	2.4%	-19.7 p.p.	22.0%	+8.0 p.p.	14.0%	-3.9 p.p.	17.9%	-0.4 p.p.	18.3%	-4.1 p.p.	22.4%	+0.9 p.p.	21.5%	-5.5 p.p.	26.9%	+5.1 p.p.	21.8%	-1.2 p.p.	23.0%	-7.6 p.p.	30.5%
Interest coverage	8.50×	+4.5%	8.14×	-10.8%	9.13×	-70.4%	30.86×	+7.4%	28.73×	+163.8%	10.89×	-71.0%	37.63×	+17.7%	31.96×	+175.6%	11.60×	+231.2%	3.50×	-65.5%	10.15×	+103.5%	4.99×	-77.4%	22.05×	-7.3%	23.77×	-4.6%	24.91×	-1.4%	25.27×	+48.2%	17.06×	+141.0%	7.08×	+26.7%	5.59×	-2.0%	5.70×	-1.7%	5.80×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ3'25 – Q2'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Net debt	-$2,640,114,403	-8.8%	-$2,426,617,362	+40.4%	-$4,069,829,554	-57.2%	-$2,589,150,963	-23.5%	-$2,096,923,135	+13.5%	-$2,423,000,969	-2.3%	-$2,369,173,846	-7.6%	-$2,200,830,687	-15.8%	-$1,899,747,045	-8.7%	-$1,748,270,967	-129.2%	-$762,691,019	+69.9%	-$2,531,958,450	+4.0%	-$2,637,541,916	+25.7%	-$3,551,900,988	-26.3%	-$2,812,527,505	-32.4%	-$2,123,954,536	-509.5%	$518,712,395	-72.1%	$1,857,123,924	-41.5%	$3,174,569,707	-25.8%	$4,277,655,180	+13.8%	$3,758,002,378
Net Debt / Equity	-0.15×	-2.3%	-0.15×	+40.7%	-0.25×	-60.3%	-0.16×	-17.6%	-0.14×	+17.2%	-0.16×	+2.0%	-0.17×	-15.5%	-0.14×	-10.2%	-0.13×	-3.1%	-0.13×	-129.5%	-0.06×	+73.3%	-0.21×	-25.0%	-0.17×	+14.9%	-0.19×	+13.9%	-0.23×	-32.0%	-0.17×	-584.9%	0.04×	-75.9%	0.15×	-58.6%	0.35×	-14.9%	0.42×	+1.3%	0.41×
Net Debt / EBITDA	-0.46×	-0.3%	-0.46×	+47.1%	-0.87×	-67.5%	-0.52×	-7.8%	-0.48×	+25.3%	-0.64×	-8.6%	-0.59×	-30.2%	-0.45×	-19.2%	-0.38×	-25.0%	-0.30×	-135.8%	-0.13×	+73.1%	-0.48×	-22.0%	-0.39×	+20.9%	-0.50×	-37.1%	-0.36×	-23.7%	-0.29×	-505.5%	0.07×	-75.6%	0.30×	-62.3%	0.79×	-5.7%	0.83×	-22.5%	1.08×
Debt / Equity	0.03×	-45.1%	0.06×	+73.8%	0.04×	-21.1%	0.04×	-5.5%	0.05×	+23.8%	0.04×	-41.6%	0.06×	+29.9%	0.05×	-31.5%	0.07×	-27.2%	0.10×	-16.8%	0.12×	+61.5%	0.07×	+15.6%	0.06×	-4.6%	0.07×	-45.9%	0.12×	-29.9%	0.18×	-35.9%	0.28×	-15.9%	0.33×	-35.6%	0.51×	-5.7%	0.54×	+11.0%	0.49×
Current ratio	1.02×	+6.2%	0.96×	-12.2%	1.10×	+23.0%	0.89×	-4.4%	0.93×	-6.1%	0.99×	-5.9%	1.06×	-4.4%	1.10×	+9.9%	1.00×	+18.2%	0.85×	+2.4%	0.83×	-11.6%	0.94×	-1.1%	0.95×	-19.5%	1.18×	+13.6%	1.04×	+2.1%	1.02×	-16.8%	1.22×	+0.8%	1.21×	+37.6%	0.88×	-6.0%	0.94×	-5.8%	1.00×
Return on equity (ROE)	18.4%	+0.8 p.p.	17.6%	+3.0 p.p.	14.6%	-3.7 p.p.	18.4%	+0.7 p.p.	17.6%	+2.3 p.p.	15.3%	-0.1 p.p.	15.4%	-3.8 p.p.	19.2%	-0.3 p.p.	19.5%	+3.6 p.p.	15.9%	-12.0 p.p.	28.0%	+2.3 p.p.	25.7%	-2.9 p.p.	28.6%	+6.3 p.p.	22.2%	-2.8 p.p.	25.0%	+2.7 p.p.	22.3%	-8.7 p.p.	31.0%	+3.8 p.p.	27.2%	+2.6 p.p.	24.6%	-3.0 p.p.	27.6%	+13.2 p.p.	14.4%
Return on assets (ROA)	11.8%	+1.3 p.p.	10.5%	+1.6 p.p.	8.9%	-2.0 p.p.	10.9%	+0.5 p.p.	10.5%	+1.3 p.p.	9.1%	+0.1 p.p.	9.1%	-2.5 p.p.	11.6%	-0.1 p.p.	11.7%	+3.3 p.p.	8.4%	-6.6 p.p.	15.0%	+1.2 p.p.	13.8%	-2.9 p.p.	16.7%	+2.8 p.p.	13.9%	+2.2 p.p.	11.7%	+0.6 p.p.	11.2%	-6.6 p.p.	17.7%	+2.8 p.p.	14.9%	+2.7 p.p.	12.2%	-1.9 p.p.	14.1%	+6.2 p.p.	7.9%
Book value / share	$1.10	+7.0%	$1.02	+1.4%	$1.01	-1.8%	$1.03	+5.1%	$0.98	+4.6%	$0.94	+4.4%	$0.90	-6.8%	$0.96	+5.0%	$0.92	+4.5%	$0.88	+0.6%	$0.87	+13.6%	$0.77	-23.7%	$1.01	-29.2%	$1.42	+12.6%	$1.26	+66.4%	$0.76	-19.6%	$0.94	+20.4%	$0.78	+34.8%	$0.58	+1.9%	$0.57	-0.2%	$0.57

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

This year (YTD) $0.01/share · yield 0.32%

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

Ambev S.A. trades on 5 exchanges. Prices on this page are the NYSE ADR (ABEV).

Exchange	Ticker	Currency
NYSEpriced here	ABEV	USD
B3 (São Paulo)	ABEV3	BRL
Frankfurt	AMNA	EUR
Mexico (BMV)	ABEV	MXN
Buenos Aires (BYMA)	ABEV	ARS

Frequently Asked Questions

Why hold Ambev S.A. ABEV ADR instead of local B3 ABEV3 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is Ambev S.A. listed?

Ambev S.A. trades on 5 exchanges. The line quoted on this page is NYSE in the United States (ABEV, US dollars). It also trades on B3 (São Paulo) in Brazil (ABEV3, Brazilian reais), Frankfurt in Germany (AMNA, euros), Mexico (BMV) in Mexico (ABEV, Mexican pesos) and Buenos Aires (BYMA) in Argentina (ABEV, Argentine pesos).

On how many exchanges does Ambev S.A. trade?

5. NYSE — ABEV (USD) · B3 (São Paulo) — ABEV3 (BRL) · Frankfurt — AMNA (EUR) · Mexico (BMV) — ABEV (MXN) · Buenos Aires (BYMA) — ABEV (ARS). Prices shown on this page are the NYSE line, ABEV.

What is Ambev S.A.'s primary listing?

Ambev S.A.'s primary listing is on the B3 in Brazil, where the shares trade as ABEV3 in reais — the company's home market. The NYSE line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.

What is the difference between ABEV and ABEV3?

They are the same company and, economically, the same asset. ABEV3 is the original Brazilian share, listed on the B3 and quoted in reais. ABEV is an American Depositary Receipt over that share, listed on the NYSE and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The ABEV price therefore tracks two things: ABEV3 in reais, and the USD/BRL exchange rate.

How can I buy Ambev S.A. stock in Europe?

Ambev S.A. trades in euros on one European venue: Frankfurt in Germany (AMNA). A European broker with access to that market can buy it in EUR, with no currency conversion on your side. The price shown on this page is the NYSE line (ABEV), quoted in US dollars.

How can I buy Ambev S.A. stock in the United States?

Ambev S.A. is listed on the NYSE under ABEV, priced in US dollars. Any US brokerage offering NYSE-listed securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 14, 17:00 BRT · Market closed

Financial data last updated: August 14, 2026

← All stocks & ETFs